TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 52 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,002 | +378.0% | 16,140 | 0.0% | 0.00% | – |
| Q2 2023 | $10,669 | -17.1% | 16,140 | 0.0% | 0.00% | – |
| Q1 2023 | $12,873 | -64.7% | 16,140 | 0.0% | 0.00% | – |
| Q4 2022 | $36,476 | +14.0% | 16,140 | 0.0% | 0.00% | – |
| Q3 2022 | $32,000 | -90.5% | 16,140 | -82.2% | 0.00% | – |
| Q2 2022 | $338,000 | -68.7% | 90,711 | -45.1% | 0.00% | – |
| Q1 2022 | $1,079,000 | -43.0% | 165,345 | +1.7% | 0.00% | -100.0% |
| Q4 2021 | $1,894,000 | -35.8% | 162,560 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $2,950,000 | +59.8% | 158,407 | +82.0% | 0.00% | 0.0% |
| Q2 2021 | $1,846,000 | +56.0% | 87,030 | +49.4% | 0.00% | – |
| Q1 2021 | $1,183,000 | -14.7% | 58,243 | +11.5% | 0.00% | -100.0% |
| Q4 2020 | $1,387,000 | – | 52,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
| Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
| Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
| Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
| Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
| Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
| TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
| Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |